Repaglinide | Radio Compass News | PharmaCompass.com

Grow Your Pharma Business Digitally

X

Market Place

Sourcing support

Sourcing Support

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

All News (-)-Repaglinide

Health Canada finds Zhejiang Huahai Pharmaceuticals site non-compliant with GMP

03 Oct 2018 //

HEALTH CANADA

Meet S Srinivasan, who got 329 irrational combination drugs banned

17 Sep 2018 //

MONEY CONTROL

AIDAN: Banning 328 FDCs a step towards rectifying grave pharma situation

14 Sep 2018 //

ECONOMIC TIMES

Saridon, Panderm among over 6,000 medicines face ban

13 Sep 2018 //

ECONOMIC TIMES

Pharmascience Inc Issues Recall of pms-REPAGLINIDE Due to Out Of Specification

19 Apr 2017 //

HEALTH CANADA

Improving solubility: MilliporeSigma opens dedicated meglumine site

19 Jan 2017 //

IN PHARMATECHNOLOGIST

Standard Chem`s Generic Repaglinide (0.5,1 & 2Mg) Approved in USA For Hyperglycemia

25 Apr 2015 //

FDA

EMA Recommends Hundreds of Drugs to be Suspended Over "Flawed Studies"

24 Jan 2015 //

PHARMALOT